Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,528Revenue $M20.7Net Margin (%)-248.3Altman Z-Score25.5
Enterprise Value $M6,413EPS $-2.1Operating Margin %-259.5Piotroski F-Score1
P/E(ttm)--Beneish M-Score-3.6Pre-tax Margin (%)-280.6Higher ROA y-yN
Price/Book86.610-y EBITDA Growth Rate %--Quick Ratio4.5Cash flow > EarningsY
Price/Sales2005-y EBITDA Growth Rate %--Current Ratio4.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-212.6ROA % (ttm)-45.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-97.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M43.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ANAC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
ANACFirst Eagle Investment 2013-03-31 Sold Out -0.0017%$3.15 - $6.52
$ 149.193361%Sold Out0
ANACFirst Eagle Investment 2012-12-31 Buy $4.6 - $6.81
$ 149.192588%New holding92,390
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ANAC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

ANAC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Zane LeeSVP and Chief Medical Officer 2015-06-15Sell12,000$69.05115.35 view
Maples Kirk RSVP, Program Management 2015-06-01Sell600$70.31111.49 view
Plattner Jacob jSenior VP, Research 2015-05-15Sell8,920$63.73133.33 view
Rodriguez Carmen RSnr VP Reg Afrs & Qual. Assur. 2015-05-14Sell61,942$62.73137.05 view
Maples Kirk RSVP, Program Management 2015-05-12Sell6,060$61.07143.49 view
Maples Kirk RSVP, Program Management 2015-05-01Sell600$53.95175.63 view
Sullivan Ryan TSr. VP and General Counsel 2015-04-29Sell3,125$53.61177.37 view
BERNS PAUL LPresident and CEO 2015-04-27Sell50,000$63.64133.66 view
Plattner Jacob jSenior VP, Research 2015-04-15Sell8,920$62.81136.75 view
Maples Kirk RSVP, Program Management 2015-04-01Sell600$57.02160.79 view

Quarterly/Annual Reports about ANAC:

News about ANAC:

Articles On GuruFocus.com
Anacor Pharmaceuticals’ Q4 Was A Solid One For Investors Mar 16 2015 
Paulson Bets Again On Mallinckrodt Aug 07 2014 
3 Great Dividend Stocks at All-Time Highs Aug 19 2013 
Weekly CFO Buys Highlight Aug 19 2013 
Senior Vice President and CFO of Anacor Pharmaceuticals Inc. Geoffrey Parker Bought 43,046 Shares Jun 20 2013 
This Week's Top Insider Buys Jun 19 2013 
comment on ANAC Mar 15 2013 
Weekly CFO Buys Highlight: SSP, BMTI, POL, ANAC, CYTX Mar 26 2012 
Weekly CFO Buys Highlight: GSVC, SHO, YAVY, CMCSA, ANAC May 16 2011 

More From Other Websites
Alexion Misses on Earnings in Q2, 2015 Outlook Revised - Analyst Blog Jul 30 2015
Anacor Pharmaceuticals Outperforms the Market Jul 30 2015
Will Anacor Pharmaceuticals (ANAC) Continue to Surge Higher? - Tale of the Tape Jul 29 2015
Anacor Pharmaceuticals to Report Second Quarter 2015 Financial Results on August 6, 2015 Jul 23 2015
Anacor Pharmaceuticals to Report Second Quarter 2015 Financial Results on August 6, 2015 Jul 23 2015
Street Talk: UNFI, SUNE, AMGN & more Jul 21 2015
Anacor Pharma upgraded by Goldman and BofA/Merrill Jul 21 2015
Bristol-Myers' HIV-1 Drug Evotaz Gets European Approval - Analyst Blog Jul 17 2015
These Hot Healthcare Stocks Lead Palo Alto Investors’ Picks To Big Q2 Returns Jul 17 2015
Manager Of Hot New Biotech ETFs Explains The Strategy Jul 16 2015
Why This Biotech ETF Keeps Surging Jul 15 2015
The element that should keep Anacor Pharma soaring Jul 15 2015
Anacor Hits 52-Week High on Positive Atopic Dermatitis Data - Analyst Blog Jul 14 2015
Anacor May Have $2 Billion Drug Jul 14 2015
Anacor Pharmaceuticals (ANAC) Jumps: Stock Rises 55.9% - Tale of the Tape Jul 14 2015
Anacor Pharmaceutical's Positive Skin Cream Results Sends Stock Soaring - Stocks in the News Jul 13 2015
Anacor Pharmaceuticals (ANAC) Stock Spiked on Positive Phase 3 Study Results Jul 13 2015
US stocks surge on Greece deal Jul 13 2015
ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 13 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)